Loading company details...
Latest Form 4 (Nov 9, 2026): Faheem Hasnain (Executive Chair): Grant/Award of 321,672 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 9, 2026 | Faheem Hasnain, Executive Chair | Grant/Award | 321,672 | n/a |
| Nov 4, 2026 | Peter A. Thompson | Conversion | 196,541 | n/a |
| Nov 4, 2026 | ORBIMED ADVISORS LLC | Conversion | 196,541 | n/a |
| Nov 3, 2026 | ARCH Venture Fund X, L.P. | Purchase | 66,666 | $1000.0K |
| Nov 3, 2026 | ARCH Venture Partners XIV, L.P. | Purchase | 1,200,000 | $18.00M |
| Nov 3, 2026 | Andrew Spaventa | Conversion | 70,194 | n/a |
| Nov 3, 2026 | Faheem Hasnain, Executive Chair | Conversion | 14,913 | n/a |